SEB Asset Management AB »

Newamsterdam Pharma Co Nv shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.7M 273k 32.01

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv